Inhibition of quorum sensing in staphylococcus spp

Current Pharmaceutical Design

Volumn 21, Issue 16, 2015, Pages 2101-2108

  Brackman, Gilles ^a   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL VIRULENCE; BIOFILM; DRUG SYNTHESIS; DRUG TARGETING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS; ANIMAL; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; HUMAN; PHYSIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; HUMANS; QUORUM SENSING; STAPHYLOCOCCUS;

EID: 84929497710     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150310101014     Document Type: Article

References (94)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Rutherford ST, Bassler BL. Bacterial Quorum sensing: its role in virulence and possibilities for its control. Cold spring harb perspect Med 212; 2: 11.
3. Archer GL, Climo MW. Staphylococcus aureus bacteraemiaconsider the source. N Engl J Med 2001; 344: 55-6.
4. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 2004; 186: 1838-50.
5. Otto M. Staphylococcus epidermidis: the 'accidental' pathogen. Nat Rev Microbiol 2009; 7: 555-67.
6. Projan SJ. Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 2003; 6: 1-4.
7. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. The American Journal of Medicine 2006; 119: S3-S10.
8. Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 2005; 21: 319-46.
9. Rezzonico F, Duffy B. Lack of genomic evidence of AI-2 receptors suggests a non-quorum sensing role for luxS in most bacteria. BMC Microbiol 2008; 8: 154.
10. Doherty N, Holden MT, Qazi SN, Williams P, Winzer K. Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing. J Bacteriol 2006; 188: 2885-97.
11. Winzer K, Hardie KR, Williams P. Bacterial cell-to-cell communication: sorry, can't talk now - gone to lunch! Curr Opin Microbiol 2002; 5: 216-22.
12. Kleerebezem M, Quadri LE, Kuipers OP, de Vos WM. Quorum sensing by peptide pheromones and two-component signaltransduction systems in Gram-positive bacteria. Mol Microbiol 1997; 24: 895-904.
13. Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 2005; 437: 48-54.
14. Dunny GM, Leonard BA. Cell-cell communication in grampositive bacteria. Annu Rev Microbiol 1997; 51: 527-64.
15. Zhang L, Lin J, Ji G. Membrane anchoring of the AgrD N-terminal amphipathic region is required for its processing to produce a quorum- sensing pheromone in Staphylococcus aureus. J Biol Chem 2004; 279: 19448-56.
16. Kavanaugh JS, Thoendel M, Horswill AR. A role for type I signal peptidase in Staphylococcus aureus quorum sensing. Mol Microbiol 2007; 65: 780-98.
17. Lyon GJ, Novick RP. Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides 2004; 25: 1389-1403.
18. Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu Rev Genet 2008; 42: 541-64.
19. Dunman PM, Murphy E, Haney S, et al. Transcription profilingbased identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 2001; 183: 7341-53.
20. Balaban N, Goldkorn T, Nhan RT, et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 1998; 280: 438-40.
21. Shaw LN, Jonsson IM, Singh VK, Tarkowski A, Stewart GC. Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect Immun 2007; 75: 4519-27.
22. Kiran MD, Adikesavan NV, Cirioni O, et al. Discovery of a quorum sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol. Pharmacol 2008; 73: 1578-86.
23. Kiran MD, Akiyoshi DE, Giacometti A, Cirioni O, Scalise G, Balaban N. OpuC-an ABC transporter that is associated with Staphylococcus aureus pathogenesis. Int J Artif Organs 2009; 32: 600-10.
24. Lina G, Jarraud S, Ji G, et al. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol Microbiol 1998; 28: 655-62.
25. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 2001; 55: 165-99.
26. Xavier KB, Bassler BL. LuxS quorum sensing: more than just a numbers game. Curr Opin Microbiol 2003; 6: 191-7.
27. Taga ME. Bacterial signal destruction. ACS Chem Biol 2007; 2: 89-92.
28. Schauder S, Shokat K, Surette MG, Bassler BL. The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol 2001; 41: 463-76.
29. Pei D, Zhu J. Mechanism of action of S-ribosylhomocysteinase (LuxS). Curr Opin Chem Biol 2004; 8: 492-97.
30. Alfaro JF, Zhang T, Wynn DP, Karschner EL, Zhou ZS. Synthesis of LuxS inhibitors targeting bacterial cell-cell communication. Org Lett 2004; 6: 3043-6.
31. Chen X, Schauder S, Potier N, et al. Structural identification of a bacterial quorum-sensing signal containing boron. Nature 2002; 415: 545-9.
32. McKenzie KM, Meijler MM, Lowery CA, Boldt GE, Janda KD. A furanosyl-carbonate autoinducer in cell-to-cell communication of V. harveyi. Chem Commun (Camb) 2005; 38: 4863-5.
33. Blehert DS, Palmer RJ Jr, Xavier JB, Almeida JS, Kolenbrander PE. Autoinducer 2 production by Streptococcus gordonii DL1 and the biofilm phenotype of a luxS mutant are influenced by nutritional conditions. J Bacteriol 2003; 185: 4851-60.
34. Miller ST, Xavier KB, Campagna SR, et al. Salmonella typhimurium recognizes a chemically distinct form of the bacterial quorum- sensing signal AI-2. Mol Cell 2004; 15: 677-87.
35. Zhao L, Xue T, Shang F, Sun H, Sun B. Staphylococcus aureus AI- 2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence. Infect Immun 2010; 78: 3506-15.
36. Li M, Villaruz AE, Vadyvaloo V, Sturdevant DE, Otto M. AI-2- dependent gene regulation in Staphylococcus epidermidis, BMC Microbiology 2008; 8: 4.
37. Yu D, Zhao L, Xue T, Sun B. Staphylococcus aureus autoinducer-2 quorum sensing decreases biofilm formation in an icaR-dependent manner. BMC Microbiology 2012; 12: 288.
38. Pratten J, Foster SJ, Chan PF, Wilson M, Nair SP. Staphylococcus aureus accessory regulators: expression within biofilms and effect on adhesion. Microbes Infect 2001; 3: 633-7.
39. Vuong C, Saenz HL, Götz F, Otto M. Impact of the agr quorumsensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 2000; 182: 1688-93.
40. Parker CT, Sperandio V. Cell-to-cell signalling during pathogenesis. Cell Microbiol 2009; 11: 363-9.
41. Kuehl R, Al-Bataineh S, Gordon O, et al. Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxS repression. Antimicrob Agents Chemother 2009; 53: 4159-66.
42. Shenkman B, Varon D, Tamarin I, et al. Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions. J Med Microbiol 2002; 51: 747-54.
43. Raina S, De Vizio D, Odell M, Clements M, Vanhulle S, Keshavarz T. Microbial quorum sensing: a tool or a target for antimicrobial therapy? Biotechnol Appl Biochem 2009; 54: 65-84.
44. George EA, Muir TW. Molecular mechanisms of agr quorum sensing in virulent staphylococci. Chembiochem 2007; 8: 847-55.
45. Roux A, Payne SM, Gilmore MS. Microbial telesensing: probing the environment for friends, foes, and food. Cell Host Microbe 2009; 6: 115-24.
46. Yarwood JM, Schlievert PM. Quorum sensing in Staphylococcus infections. J Clin Invest 2003; 112: 1620-5.
47. Balaban N, Novick RP. Translation of RNAIII, the Staphylococcus aureus agr regulatory RNA molecule, can be activated by a 3'-end deletion. FEMS Microbiol Lett 1995; 133: 155-61.
48. Kong KF, Vuong C, Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int J Med Microbiol 2006; 296: 133-9.
49. Abdelnour A, Arvidson S, Bremell T, Rydén C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993; 61: 3879-85.
50. Cheung AL, Eberhardt KJ, Chung E, et al. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 1994; 94: 1815-22.
51. Booth MC, Cheung AL, Hatter KL, Jett BD, Callegan MC, Gilmore MS. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun 1997; 65: 1550-6.
52. Gillaspy AF, Hickmon SG, Skinner RA, Thomas JR, Nelson CL, Smeltzer MS. Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun 1995; 63: 3373-80.
53. Heyer G, Saba S, Adamo R, et al. Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect Immun 2002; 70: 127-33.
54. Blevins JS, Elasri MO, Allmendinger SD, et al. Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection. Infect Immun 2003; 71: 516-23.
55. Shopsin B, Drlica-Wagner A, Mathema B, Adhikari RP, Kreiswirth BN, Novick RP. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J Infect Dis 2008; 198: 1171-4.
56. Traber KE, Lee E, Benson S, et al. agr function in clinical Staphylococcus aureus isolates. Microbiology 2008; 154: 2265-74
57. Wesson CA, Liou LE, Todd KM, Bohach GA, Trumble WR, Bayles KW. Staphylococcus aureus Agr and Sar global regulators influence internalization and induction of apoptosis. Infect Immun 1998; 66: 5238-43.
58. Goerke C, Campana S, Bayer MG, Döring G, Botzenhart K, Wolz C. Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro. Infect Immun 2000; 68: 1304-11.
59. Yarwood JM, McCormick JK, Paustian ML, Kapur V, Schlievert PM. Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo. J Bacteriol 2002; 184: 1095-101.
60. Wright JS 3rd, Traber KE, Corrigan R, Benson SA, Musser JM, Novick RP. The agr radiation: an early event in the evolution of staphylococci. J Bacteriol 2005; 187: 5585-94.
61. Xu L, Li H, Vuong C, et al. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect Immun 2006; 74: 488-96
62. Thoendel M, Horswill AR. Biosynthesis of peptide signals in grampositive bacteria. Adv Appl Microbiol 2010; 71: 91-112.
63. Buzder-Lantos P, Bockstael K, Anné J, Herdewijn P. Substrate based peptide aldehyde inhibits bacterial type I signal peptidase. Bioorg Med Chem Lett 2009; 19: 2880-3.
64. Nakayama J, Uemura Y, Nishiguchi K, Yoshimura N, Igarashi Y, Sonomoto K. Ambuic acid inhibits the biosynthesis of cyclic peptide quormones in gram-positive bacteria. Antimicrob Agents Chemother 2009; 53: 580-6.
65. Chan WC, Coyle BJ, Williams P. Virulence regulation and quorum sensing in staphylococcal infections: competitive AgrC antagonists as quorum sensing inhibitors. J Med Chem 2004; 47: 4633-41.
66. Gordon CP, Williams P, Chan WC. Attenuating Staphylococcus aureus virulence gene regulation: A medicinal chemistry perspective. J Med Chem 2013; 56: 1389-404.
67. Park J, Jagasia R, Kaufmann GF, et al. Infection control by antibody disruption of bacterial quorum sensing signalling. Chem Biol 2007; 14: 1119-27.
68. Zhao G, Wan W, Mansouri S, et al. Chemical synthesis of Sribosyl- L-homocysteine and activity assay as a LuxS substrate. Bioorg Med Chem Lett 2003; 13: 3897-900.
69. Shen G, Rajan R, Zhu J, Bell CE, Pei D. Design and synthesis of substrate and intermediate analogue inhibitors of Sribosylhomocysteinase. J Med Chem 2006; 49: 3003-11.
70. Han X, Lu C. Biological activity and identification of a peptide inhibitor of LuxS from Streptococcus suis serotype 2. FEMS Microbiol Lett 2009; 294: 16-23.
71. Zhang M, Jiao XD, Hu YH, Sun L. Attenuation of Edwardsiella tarda virulence by small peptides that interfere with LuxS/autoinducer type 2 quorum sensing. Appl Environ Microbiol 2009; 75: 3882-90.
72. Gutierrez JA, Crowder T, Rinaldo-Matthis A, Ho MC, Almo SC, Schramm VL. Transition state analogs of 5'-methylthioadenosine nucleosidase disrupt quorum sensing. Nat Chem Biol 2009; 5: 251-7.
73. Longshaw AI, Adanitsch F, Gutierrez JA, Evans GB, Tyler PC, Schramm VL. Design and synthesis of potent "sulfur-free" transition state analogue inhibitors of 5'-methylthioadenosine nucleosidase and 5'-methylthioadenosine phosphorylase. J Med Chem 2010; 53: 6730-46.
74. Lyon GJ, Wright JS, Muir TW, Novick RP. Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus. Biochemistry 2002; 41: 10095-104.
75. Mayville P, Ji G, Beavis R, et al. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci USA 1999; 96: 1218-23.
76. Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science 1997; 276: 2027-30.
77. Jensen RO, Winzer K, Clarke SR, Chan WC, Williams P. differential recognition of Staphylococcus aureus quorum-sensing signals depend on both extracellular loops 1 and 2 of the transmembrane sensor AgrC. JMol Biol 2008; 381: 300-9.
78. George EA, Novick RP, Muir TW. Cyclic peptide inhibitors of staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. J Am Chem Soc 2008; 130: 4914-24.
79. Scott RJ, Lian LY, Muharram SH, et al. Side-chain-to-tail thiolactone peptide inhibitors of the staphylococcal quorum-sensing system. Bioorg Med Chem Lett 2003; 13: 2449-53.
80. McDowell P, Affas Z, Reynolds C, et al. Structure activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus. Mol Microbiol 2001; 41: 503-12.
81. Fowler SA, Stacy DM, Blackwell HE. Design and synthesis of macrocyclic peptomers as mimics of a quorum sensing signal from Staphylococcus aureus. Org Lett 2008; 10: 2329-32.
82. Mansson M, Nielsen A, Kjaerulff L, et al. Inhibition of virulence gene expression in staphylococcus aureus by novel depsipeptides from a marine Photobacterium. Mar Drugs 2011; 9: 2537-52.
83. Li J, wang W, Xu SX, Magarvey NA, McCormick JK. Lactobacillus teuteri produced cyclic dipeptides quanch agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc Natl Acad Sci USA 2011; 108: 3360-5.
84. Sklar LA, Gresham HD. Probe report: C094-0010-A small molecule that targets a signaling pathway in AIP-dependent bacterial quorum sensing of S. aureus Agr3 agr locus genotype. Grant number: NIH 1 X01 MH078952-01 2011.
85. Cirioni O, Mocchegiani F, Cacciatore I, et al. Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection. Peptides 2012; 40: 77-81.
86. Novick RP, Ross HF, Figueiredo AMS, Abramochkin G, Muir T. Activation and inhibition of the staphylococcal AGR system. Science 2000; 287: 391a.
87. Ji G, Beavis RC, Novick RP. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci USA 1995; 92: 12055-9.
88. Otto M, Süssmuth R, Vuong C, Jung G, Götz F. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett 1999; 450: 257-62.
89. Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother 2011; 55: 2655-61.
90. Sidote DJ, Barbieri CM, Wu T, Stock AM. Structure of the staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding. Structure 2008; 16: 727-35.
91. Leonard PG, Bezar IF, Sidote DJ, Stock AM. Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding. Biochemistry 2012; 51: 10035-43.
92. Matsushita M, Janda KD. Histidine kinases as targets for new antimicrobial agents. Bioorg med chem 2002; 10: 855-67.
93. Barrett JF, Goldschmidt RM, Lawrence LE, et al. Antibacterial agents that inhibit two-component signal transduction systems. Proc Natl Acad Sci USA 1998; 95: 5317-22.
94. Harraghy N, Kerdudou S, Herrmann M. Quorum-sensing systems in staphylococci as therapeutic targets. Anal Bioanal Chem 2007; 387: 437-44.